Hillary Clinton's 10-year-plan worth $2B to eradicate Alzheimer's by 2025
The most common form of dementia, Alzheimer's disease, is expected to have a permanent cure by 2025. A new 10-year-plan announced by Hillary Clinton aims to conduct groundbreaking research to prevent and effectively treat Alzheimer's by 2025.
In her proposal, Clinton announced an investment of $2 billion in research to make it possible to eliminate Alzheimer's. In addition, the plan laid by the former United States Secretary of State outlines new measures to improve caregiving to those who suffer from Alzheimer's and provide support to family caregivers.
According to Clinton's fact sheet, the new plan aims to achieve what was once thought to be a remote possibility – to develop a cure for Alzheimer's. In the past 10 years, no new drug for treatment of Alzheimer's has been approved by the US Food and Drug Administration (FDA).
“It invests the needed resources, organizes a broad national effort, and inspires leaders in the public, nonprofit, and private sectors to develop effective interventions to prevent and effectively treat Alzheimer’s and related dementias, thereby making a cure possible,” states the fact sheet.
The $2 billion per year funding will see a collaboration between researchers, physicians and scientists and other public-private firms. A top-flight team appointed by Clinton will oversee the progress of the plan to make sure that the 2025 goal pushes through. Clinton is also expected to work with stakeholders to recruit participants for the clinical trials involving new therapies.
It is estimated that nearly five million Americans currently suffer from Alzheimer's. If no action is taken, the suffering population is expected to grow threefold to 15 million by 2050. It is expected that the total cost to treat Alzheimer's may exceed $1 trillion a year in the US, reports PerfScience.
Clinton's new plan has raised hopes among sufferers who fear of losing their life because of the sixth leading cause of deaths in the United States.
Contact the writer at feedback@ibtimes.com.au, or let us know what you think below.
